Pennsylvania coroner reports measles death, toll rises to six

Pennsylvania's Franklin County coroner on Monday reported a measles-associated death in a 39-year-old woman with several ​health conditions, the state's sixth death linked to the disease.

Bristol Myers therapy slows rare tumor progression, bolstering radiopharma push

Bristol Myers Squibb said on Monday its experimental radiopharmaceutical therapy significantly delayed disease ​progression in patients with rare, advanced gastrointestinal and pancreatic tumors that had progressed after earlier treatment.

Bausch + Lomb CEO Saunders departs, Chairman Appio named interim chief

Bausch + Lomb said on Monday that CEO Brent ​Saunders will leave the eye-care company by mutual agreement with its board, sending its US-listed shares down more ‌than 7%.

Steris doubles down on healthcare consumables with $2.1 billion Xodus buy

Medical equipment maker Steris will buy privately held Xodus ​Medical for $2.1 billion, adding surgical products designed to improve safety for patients and operating-room staff to its healthcare consumables business.

Gen Z is feeling nostalgic. Experts say it might be a good thing

In a recent national survey, 68% of Gen Z respondents reported feeling nostalgic for eras before their lifetime, while 73% said they were drawn to the era's styles, media and hobbies.

Bristol Myers radiopharma cancer drug slows rare tumor progression in study

Bristol Myers Squibb said on Monday its experimental radiopharmaceutical cancer therapy ​significantly delayed disease progression in patients with rare, advanced gastrointestinal and pancreatic tumors that had progressed after earlier treatment.

Bristol Myers' lung disease drug succeeds at lower dose in late-stage trial

Bristol Myers Squibb said on Monday a lower dose of its ​experimental drug slowed the progression of a serious lung-scarring disease, putting it on track to be a first-of-its-kind treatment if approved.